334 related articles for article (PubMed ID: 9482395)
1. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.
Jongerius JM; Wester M; Cuypers HT; van Oostendorp WR; Lelie PN; van der Poel CL; van Leeuwen EF
Transfusion; 1998 Jan; 38(1):56-9. PubMed ID: 9482395
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay.
Levicnik-Stezinar S
Clin Lab; 2004; 50(1-2):49-51. PubMed ID: 15000220
[TBL] [Abstract][Full Text] [Related]
3. The Thr to Met substitution of amino acid 118 in hepatitis B virus surface antigen escapes from immune-assay-based screening of blood donors.
Yang Y; Nan Y; Cai J; Xu J; Huang Z; Cai X
J Gen Virol; 2016 May; 97(5):1210-1217. PubMed ID: 26873737
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
5. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
[TBL] [Abstract][Full Text] [Related]
6. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
[TBL] [Abstract][Full Text] [Related]
8. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
Weber B; Mühlbacher A; Melchior W
J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
[TBL] [Abstract][Full Text] [Related]
9. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
10. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
[TBL] [Abstract][Full Text] [Related]
11. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
12. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor.
Datta S; Banerjee A; Chandra PK; Chakraborty S; Basu SK; Chakravarty R
J Clin Virol; 2007 Nov; 40(3):255-8. PubMed ID: 17869170
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors.
Harris BJ; Holzmayer V; Qureshi H; Khan MA; Khan SA; Salamat N; Jafri S; Brennan CA
PLoS One; 2017; 12(6):e0178988. PubMed ID: 28582431
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
Ye X; Li T; Zhang R; Liu H; Zeng J; Hong W; Lu L; Zhu W; Li S; Xu M; Wu S; Chen L
Transfusion; 2020 Jul; 60(7):1476-1482. PubMed ID: 32358842
[TBL] [Abstract][Full Text] [Related]
15. HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant.
Louisirirotchanakul S; Kanoksinsombat C; O'Charoen R; Fongsatikul L; Puapairoj C; Lulitanond V; Appassakij H; Promwong C; Wasi C
Viral Immunol; 2006; 19(1):108-14. PubMed ID: 16553556
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays.
Kfoury Baz EM; Zheng J; Mazuruk K; Van Le A; Peterson DL
Transfus Med; 2001 Oct; 11(5):355-62. PubMed ID: 11696228
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
18. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.
Ijaz S; Torre F; Tedder RS; Williams R; Naoumov NV
J Med Virol; 2001 Mar; 63(3):210-6. PubMed ID: 11170059
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.
Pivert A; Servant-Delmas A; Lunel-Fabiani F; Le Guillou-Guillemette H; Laperche S; Ducancelle A
J Med Virol; 2015 Mar; 87(3):529-35. PubMed ID: 25170961
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
